# Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

> **NCT00195013** · PHASE3 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 30 (actual)

## Conditions studied

- Peripheral Neuropathy
- Breast Cancer

## Interventions

- **DRUG:** glutamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00195013
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195013, "Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00195013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*